Lutronic Features the CLARITY(TM) Dual-Wavelength Platform at the 2013 International Master Course on Aging Skin (IMCAS) in Paris

Share Article

Lutronic, a leading innovator of aesthetic and medical advanced laser and related technology, will feature the CLARITY™, a long-pulsed Alexandrite and Nd:YAG 2-in-1 platform for multiple applications, at the 15th Annual Congress, IMCAS 2013, to begin on January 31st 2013, in Paris, France.

Clarity dual-wavelength platform

CLARITY

Lutronic has continued to impress me with their technology. I love how easy to use each of their products are and my patients love the results they get.

Lutronic, a leading innovator of aesthetic and medical advanced laser and related technology, will feature the CLARITY™, a long-pulsed Alexandrite and Nd:YAG 2-in-1 platform for multiple applications, at the 15th Annual Congress, IMCAS 2013, to begin on January 31st 2013, in Paris, France.

CLARITY is one of the most versatile dual-wavelength platforms on the market, with multiple indications for top aesthetic laser physicians worldwide. With two workhorse wavelengths, the long-pulsed 755 nm Alexandrite and 1064 nm Nd:YAG, in one easy- to-use device, physicians may gently remove pigmented lesions, unwanted hair, tighten skin, and ameliorate the appearance of vascular lesions. CLARITY received the CE mark in June 2012; it is not yet for sale in the US, and is pending FDA clearance.

“Lutronic works diligently to provide practitioners solid technology, designed with innovative features that add true value,” stated Ann Marie Collier, Global Products & Marketing Officer. “Our newest product portfolio addition, CLARITY, offers single fiber delivery for all spot-sizes and both wavelengths which provide added user convenience, increase treatment speeds, and reduce costs across many applications. CLARITY also features our intuitive graphical user interface that Lutronic customers recognize, appreciate and praise.”

CLARITY joins Lutronic’s robust portfolio that is hailed in the aesthetic industry for its high value devices that doctors find both intuitive and convenient. Also being featured by Lutronic at IMCAS will be SPECTRA™, a Dual-pulsed Q-switched Nd:YAG laser and the first of its kind to be FDA cleared for the treatment of melasma; INFINI, a 2-in-1 fractional RF system which has two treatment modalities, MFR and SFR, in one platform; and ADVANTAGE, a high energy pulsed diode laser system for hair removal and permanent hair reduction.

“Lutronic has continued to impress me with their technology. I love how easy to use each of their products are and my patients love the results they get,” stated Dr. Kubilay Yucel, a practicing dermatologist in Turkey. “CLARITY is another fine addition to my practice.”

Lutronic will also be hosting the annual Lutronic Laser Dinner Symposium, taking place at the Hôtel Concorde La Fayette. Learn about the latest advancements in laser technology from leading experts. Stop by our IMCAS Paris booth #B9 or register today for the Lutronic Laser Dinner Symposium, scheduled for February 2nd. Seating is limited, stop by booth #B9 to register.

About LUTRONIC
Lutronic, a leading innovator in advanced aesthetic and medical laser and related technology, was established over 15 years ago to bring intuitive, robust, versatile devices that are affordable and efficacious to the worldwide medical community. Committed to improving medicine, Lutronic partners with key opinion leaders to advance science and ensure the efficacy of its systems. All systems are versatile and offer multiple setting and treatment options for customized treatments, which optimize outcomes for a wide variety of conditions and treatments including melasma, tattoo removal, soft tissue incision, vascular lesions, hair removal, wrinkle reduction, rejuvenation, body/face contouring, chronic pain, healing and more.

With a focus on physician needs and patient outcomes, Lutronic dedicates time and funding toward the development of devices that offer features and improvements not found in today’s market. Devoting more than 15% of revenues to R&D, Lutronic holds more than 130 current and pending patents worldwide. With more than 230 employees worldwide, Lutronic has offices in the US, Korea, China, and Japan, a worldwide network of distributors, focused R&D centers in both the US and Korea, and is ever expanding.

For more information about Lutronic visit: http://www.lutronic.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tracy Evleshin
Visit website